BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15494858)

  • 1. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
    Liang SX; Chambers SK; Cheng L; Zhang S; Zhou Y; Zheng W
    Int J Surg Pathol; 2004 Oct; 12(4):319-31. PubMed ID: 15494858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.
    Zheng W; Liang SX; Yi X; Ulukus EC; Davis JR; Chambers SK
    Int J Gynecol Pathol; 2007 Jan; 26(1):38-52. PubMed ID: 17197896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
    Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
    Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
    Lu B; Chen Q; Zhang X; Cheng L
    Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
    Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
    Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial intraepithelial carcinoma: a case report and brief review.
    Ram M; Bharadwaj M; Yadav R
    Indian J Pathol Microbiol; 2008; 51(4):512-4. PubMed ID: 19008579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.
    Sherman ME; Bitterman P; Rosenshein NB; Delgado G; Kurman RJ
    Am J Surg Pathol; 1992 Jun; 16(6):600-10. PubMed ID: 1599038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
    Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
    Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
    Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and bcl-2 expression in invasive and pre-invasive uterine papillary serous carcinoma and atrophic endometrium.
    Busmanis I; Ho TH; Tan SB; Khoo KS
    Ann Acad Med Singap; 2005 Aug; 34(7):421-5. PubMed ID: 16123814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
    Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
    Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.
    Fadare O; Zheng W
    Diagn Pathol; 2008 Feb; 3():6. PubMed ID: 18261213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
    McCluggage WG; Sumathi VP; McManus DT
    Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype of papillary serous peritoneal carcinomas.
    Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
    Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).
    Fader AN; Starks D; Gehrig PA; Secord AA; Frasure HE; O'Malley DM; Tuller ER; Rose PG; Havrilesky LJ; Moore KN; Huh WK; Axtell AE; Kelley JL; Zanotti KM;
    Gynecol Oncol; 2009 Nov; 115(2):244-8. PubMed ID: 19712966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.